socalTechnews
Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
    • About
  • Membership
  • About
  • Contact Us
    		•
    Search News
    Thursday, November 16, 2006

    Pharmion Acquires Cabrellis Pharmaceuticals
    Boulder, Colorado-based Pharmion said late yesterday that it has acquired San Diego, California-based Cabrellis Pharmaceuticals, a company developing oncology drugs for the treatment of small cell lung cancer. The deal was worth $59M, along with two additional payments of $12.5M upon approval of the Cabrellis amrubicin product. Cabrellis is a venture-backed firm with investments from Domain Associates, Forward Ventures, Lilly Ventures, Novo A/S, ProQuest Investments, RBC Capital Partners, RiverVest Venture Partners, and S.R. One, Limited.
    posted on Thursday, November 16, 2006

    Related stories:
    > Cabrellis Pharmaceuticals Adds Regulatory VP
    > Cabrellis Pharmaceuticals Raises $27.5M
    > Tragara Pharmaceuticals Raises $40M
    > NovaCardia Appoints CFO
    > Valeant Pharmaceuticals Sells Argentina Ops

    RSS Feed
    subscri be via emailNewsletter


    Previous news:

     Friday, August 29, 2008
    Thursday, August 28, 2008
    Wednesday, August 27, 2008
    Tuesday, August 26, 2008
    Monday, August 25, 2008